Extrawell Pharmaceutical Holdings Limited (0858.HK)
HKD 0.05
(2.04%)
HKD 0.05
(2.04%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 120.41 Million HKD | -80.44% |
| 2022 | 615.58 Million HKD | 3.0% |
| 2021 | 597.66 Million HKD | 1.95% |
| 2020 | 586.23 Million HKD | 1.62% |
| 2019 | 576.89 Million HKD | 2.65% |
| 2018 | 561.99 Million HKD | 1.41% |
| 2017 | 554.17 Million HKD | 1.2% |
| 2016 | 547.58 Million HKD | 1.02% |
| 2015 | 542.02 Million HKD | 2069.68% |
| 2014 | 24.98 Million HKD | -80.57% |
| 2013 | 128.59 Million HKD | 103.58% |
| 2012 | 63.16 Million HKD | 1214.1% |
| 2011 | 4.8 Million HKD | 0.0% |
| 2010 | - HKD | 0.0% |
| 2009 | - HKD | 0.0% |
| 2008 | - HKD | 0.0% |
| 2007 | - HKD | 0.0% |
| 2006 | - HKD | -100.0% |
| 2005 | 4.63 Million HKD | 0.0% |
| 2004 | - HKD | 0.0% |
| 2003 | - HKD | 0.0% |
| 2002 | - HKD | 0.0% |
| 2001 | - HKD | -100.0% |
| 2000 | 19.82 Million HKD | 12.05% |
| 1999 | 17.68 Million HKD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 FY | 120.41 Million HKD | -80.44% |
| 2023 Q2 | 623.71 Million HKD | 0.0% |
| 2023 Q4 | 120.41 Million HKD | 0.0% |
| 2022 Q2 | 604.17 Million HKD | 0.0% |
| 2022 FY | 615.58 Million HKD | 3.0% |
| 2022 Q4 | 615.58 Million HKD | 0.0% |
| 2021 Q2 | 591.64 Million HKD | 0.0% |
| 2021 Q4 | 597.66 Million HKD | 0.0% |
| 2021 FY | 597.66 Million HKD | 1.95% |
| 2020 Q4 | 586.23 Million HKD | 0.0% |
| 2020 FY | 586.23 Million HKD | 1.62% |
| 2020 Q2 | 581.35 Million HKD | 0.0% |
| 2019 FY | 576.89 Million HKD | 2.65% |
| 2019 Q2 | 566.45 Million HKD | 0.0% |
| 2019 Q4 | 576.89 Million HKD | 0.0% |
| 2018 Q2 | 45.56 Million HKD | 0.0% |
| 2018 Q4 | 49.63 Million HKD | 0.0% |
| 2018 FY | 561.99 Million HKD | 1.41% |
| 2017 FY | 554.17 Million HKD | 1.2% |
| 2017 Q4 | 41.81 Million HKD | 0.0% |
| 2017 Q2 | 38.38 Million HKD | 0.0% |
| 2016 Q2 | 32.33 Million HKD | 0.0% |
| 2016 FY | 547.58 Million HKD | 1.02% |
| 2016 Q4 | 35.22 Million HKD | 0.0% |
| 2015 Q1 | - HKD | -100.0% |
| 2015 Q4 | 29.67 Million HKD | 0.0% |
| 2015 FY | 542.02 Million HKD | 2069.68% |
| 2015 Q2 | 27.22 Million HKD | 0.0% |
| 2014 Q1 | - HKD | -100.0% |
| 2014 FY | 24.98 Million HKD | -80.57% |
| 2014 Q4 | 24.98 Million HKD | 0.0% |
| 2014 Q3 | - HKD | -100.0% |
| 2014 Q2 | 125.9 Million HKD | 0.0% |
| 2013 Q2 | 116.27 Million HKD | 0.0% |
| 2013 Q4 | 128.59 Million HKD | 0.0% |
| 2013 Q3 | - HKD | -100.0% |
| 2013 Q1 | - HKD | -100.0% |
| 2013 FY | 128.59 Million HKD | 103.58% |
| 2012 Q2 | 5.99 Million HKD | 0.0% |
| 2012 Q1 | - HKD | -100.0% |
| 2012 FY | 63.16 Million HKD | 1214.1% |
| 2012 Q4 | 5.99 Million HKD | 0.0% |
| 2012 Q3 | - HKD | -100.0% |
| 2011 Q4 | 4.8 Million HKD | 0.0% |
| 2011 FY | 4.8 Million HKD | 0.0% |
| 2011 Q2 | 4.8 Million HKD | 0.0% |
| 2010 FY | - HKD | 0.0% |
| 2010 Q4 | - HKD | 0.0% |
| 2010 Q2 | - HKD | 0.0% |
| 2009 Q4 | - HKD | 0.0% |
| 2009 FY | - HKD | 0.0% |
| 2008 FY | - HKD | 0.0% |
| 2007 FY | - HKD | 0.0% |
| 2006 FY | - HKD | -100.0% |
| 2005 FY | 4.63 Million HKD | 0.0% |
| 2004 FY | - HKD | 0.0% |
| 2003 FY | - HKD | 0.0% |
| 2002 FY | - HKD | 0.0% |
| 2001 FY | - HKD | -100.0% |
| 2000 FY | 19.82 Million HKD | 12.05% |
| 1999 FY | 17.68 Million HKD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 6.8 Million HKD | -1668.135% |
| Grand Pharmaceutical Group Limited | 3.4 Billion HKD | 96.463% |
| Wai Yuen Tong Medicine Holdings Limited | 460.94 Million HKD | 73.878% |
| Qianhai Health Holdings Limited | 487 Thousand HKD | -24624.846% |
| Lee's Pharmaceutical Holdings Limited | 204.14 Million HKD | 41.016% |
| Essex Bio-Technology Limited | 294.02 Million HKD | 59.047% |
| Tongfang Kontafarma Holdings Limited | 333.82 Million HKD | 63.93% |
| PuraPharm Corporation Limited | 424.77 Million HKD | 71.653% |
| SSY Group Limited | 3.37 Billion HKD | 96.431% |
| JBM (Healthcare) Limited | 133.4 Million HKD | 9.742% |
| Jacobson Pharma Corporation Limited | 749.37 Million HKD | 83.932% |
| China Resources Pharmaceutical Group Limited | 85.84 Billion HKD | 99.86% |